Novartis is further evaluating Femara compared to tamoxifen in the adjuvant setting.
弗隆用作辅助药时,诺华以他莫昔芬为对照,对它做了进一步的评估.
互联网
Tamoxifen approved by FDA for marketing as a treatment drug.
FDA批准他末昔芬作为治疗药物进入市场.
互联网
Many women stop tamoxifen therapy well before their 5 - year course is up.
许多妇女在她们的5年治疗期结束前停用他莫西芬.
互联网
I went and got the tamoxifen and some juice.
我去拿了他莫西酚和一些果汁.
互联网
This tamoxifen might work.
他莫西酚可能起作用呢.
互联网
Hormone therapy includes tamoxifen and aromatase inhibitors.
激素治疗包括三苯氧胺和芳香酶抑制剂.
互联网
Anti - estrogen drugs such as tamoxifen ( Novaldex ) are a standard treatment for hormone - dependent breast cancer.
抗 雌激素药物如他莫 昔 酚是激素依赖性乳癌的标准治疗.
互联网
Under age 40 years with abnormal uterine bleeding and risk factors ( eg, chronic anovulation, obesity, tamoxifen ).
年龄小于40,有异常子宫出血及高危因素 ( 如:慢性无排卵 、 肥胖 、 使用三苯氧胺 ).
互联网
Tamoxifen improves bone density in postmenopausal women, and there is some evidence of fracture reduction.
三苯氧胺改善绝经后妇女的骨密度, 并可减少骨折的发生.
互联网
Despite, tamoxifen and another drug, raloxifene, remain an extensively used and popular treatment.
虽然存在这些副作用, 三苯氧胺和另一种同类药物-雷洛西芬已经被广泛用于乳腺癌的治疗.
互联网
Unlike tamoxifen, aromatase inhibitors do not cause menopausal symptoms, but they may increase risk of osteoporosis.
与三苯氧胺不同的是, 芳香抑制剂不会引起绝经期症状, 但可增加骨质疏松症危险.
互联网
Until these data are absolutely clear, I would avoid drugs that impact on tamoxifen metabolism.
除非数据绝对明显了, 我都会避免使用可以干扰他莫昔芬代谢的药物的.
互联网
Background Ovarian suppression plus tamoxifen a standard adjuvant treatment in premenopausal women with endocrine - responsive breast cancer.
卵巢去势加他莫昔芬是绝经前妇女激素敏感性乳腺癌的标准辅助治疗方案.
互联网